Prenatal gene test Nifty under international scrutiny amid links to Chinese military

Five countries are assessing the BGI Group test amid regulatory concerns about genetic data being sent abroad

Health regulators in five countries are examining a prenatal test that collects the DNA of women and foetuses for research after it emerged the test's manufacturer has links to China's military.

Some doctors and clinics that promoted and sold the test, marketed under the brand name Nifty, said they were unaware that Shenzhen-based BGI Group also conducts research with the Chinese military.